Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma

This study has been completed.
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: February 11, 2012
Last updated: April 14, 2015
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2015
  Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)